India approves Oxford/AstraZeneca vaccine for emergency use in major breakthrough for Covid fightback


India has given a green light for emergency use of the Oxford-AstraZeneca vaccine, making it the first jab to be granted approval by regulators in the Covid-19 pandemic’s second worst-hit country.

The Central Drugs Standard Control Organisation (CDSCO), whose experts were meeting on Friday for the second time this week came to the decision that paves the way for a near-immediate start to the inoculation process, according to Reuters.

The group was meeting a day ahead of a nationwide trial run for vaccine delivery in the country. According to Indian media reports, both AstraZeneca and the makers of a local vaccine candidate made presentations before the panel on Wednesday, while Pfizer, which has also applied for emergency authorisation sought more time to present their data.

The Oxford-AstraZeneca vaccine, branded as “Covishield” in India, is being locally produced by the Serum Institute of India (SII), the biggest vaccine manufacturer in the world. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.


Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.